Thromboembolic complications in adults with congenital heart disease are frequent and responsible for significant morbidity and mortality. Their prevention frequently requires long-term thromboprophylaxis. In this article, we discuss the specificities that must be considered when stratifying the thromboembolic risk in these patients, the different therapeutic strategies, particularly the place of direct oral anticoagulants.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.53738/REVMED.2022.18.783.1057 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!